Insider · CIK 0001902760
Wendy McDermott
Files at LXRX (LEXICON PHARMACEUTICALS, INC.). First filing -, latest -.
Wendy McDermott files SEC Form 4 as officer at LXRX (LEXICON PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Wendy McDermott has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +27,697 | - | - | 149,343 | Mar 3, 2026 |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +52,316 | - | - | 201,659 | Mar 3, 2026 |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +144,393 | - | - | 346,052 | Mar 3, 2026 |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -68,107 | $1.47 | $100k | 277,945 | Mar 3, 2026 |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -27,697 | - | - | 0 | Mar 3, 2026 |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -52,316 | - | - | 52,317 | Mar 3, 2026 |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -144,393 | - | - | 288,787 | Mar 3, 2026 |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +250,200 | $0.00 | $0 | 250,200 | Feb 17, 2026 |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +375,300 | $0.00 | $0 | 375,300 | Feb 17, 2026 |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +18,943 | - | - | 71,637 | Mar 3, 2025 |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +27,696 | - | - | 99,333 | Mar 3, 2025 |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +52,317 | - | - | 151,650 | Mar 3, 2025 |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | FTax withholding Common Stock | -30,004 | $0.67 | $20k | 121,646 | Mar 3, 2025 |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -18,943 | - | - | 0 | Mar 3, 2025 |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -27,696 | - | - | 27,697 | Mar 3, 2025 |
| Feb 28, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -52,317 | - | - | 104,633 | Mar 3, 2025 |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +649,780 | $0.00 | $0 | 649,780 | Feb 18, 2025 |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +433,180 | $0.00 | $0 | 433,180 | Feb 18, 2025 |
Questions about Wendy McDermott
Answered from the filings on this page, as of the latest one.
Is Wendy McDermott buying or selling?
Wendy McDermott has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Wendy McDermott's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Wendy McDermott has 0.
Where does Wendy McDermott file Form 4?
Wendy McDermott has filed Form 4 at LXRX (LEXICON PHARMACEUTICALS, INC.) as SVP, Human Resources. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.